AIDA 2000 Guidelines

NCT01064570 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: all-trans retinoic acid (ATRA)

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto